![John McDonald](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John McDonald
Director/Board Member at
GERON CORPORATION
Net worth: - $ as of 30/06/2026
Profile
Mr. John F.
McDonald is an Independent Director at Geron Corp., an Independent Director at Nouscom AG, a VP, Global Head-Business Development, M&A at Novo Nordisk A/S and an Operating Partner at Forbion Capital Partners Management Holding.
He is on the Board of Directors at Geron Corp., Nouscom AG and Nouscom Srl.
Mr. McDonald was previously employed as a Vice President-Business Development by Biogen, Inc., a Co-Founder by Solasia Pharma KK, a Managing Director by MPM BioImpact LLC, a Principal by Genzyme Corp., and a Vice President-Business Development by Millennium Pharmaceuticals, Inc. He also served on the board at CalciMedica Subsidiary, Inc. He received his undergraduate degree from Haas School of Business, a graduate degree from the University of California, Hastings and an MBA from Haas School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
GERON CORPORATION -.--% | 20/05/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
John McDonald active positions
| Companies | Position | Start |
|---|---|---|
| GERON CORPORATION | Director/Board Member | 07/09/2022 |
| NOVO NORDISK A/S | Corporate Officer/Principal | 01/10/2018 |
Nouscom AG
 Nouscom AG Pharmaceuticals: MajorHealth Technology Operates as an oncology company that develops immunotherapies | Director/Board Member | 05/11/2018 |
Nouscom Srl
 Nouscom Srl Miscellaneous Commercial ServicesCommercial Services Operates as a next-generation immunotherapy company that develops engineered viral vectored vaccines for treatment of cancer | Director/Board Member | - |
Former positions of John McDonald
| Companies | Position | End |
|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | 01/09/2018 |
CalciMedica Subsidiary, Inc.
 CalciMedica Subsidiary, Inc. BiotechnologyHealth Technology Engages in drug development | Director/Board Member | - |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Corporate Officer/Principal | - |
| SOLASIA PHARMA K.K. | Founder | - |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Corporate Officer/Principal | - |
Training of John McDonald
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
67
1st degree connections
12
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Geron Corp.
 Geron Corp. BiotechnologyHealth Technology Discovers and develops therapeutic products for cancer | Health Technology |
Novo Nordisk A/S
 Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
CalciMedica Subsidiary, Inc.
CalciMedica Subsidiary, Inc. BiotechnologyHealth Technology Engages in drug development | Health Technology |
MPM BioImpact LLC
 MPM BioImpact LLC Investment ManagersFinance MPM Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of biotechnology, healthcare and life science sectors. It participates in early stage capital transactions. | Finance |
University of California, Hastings
 University of California, Hastings Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Solasia Pharma KK
 Solasia Pharma KK Pharmaceuticals: MajorHealth Technology Engages in the development, sale, import and export of pharmaceutical products and medical devices | Health Technology |
Haas School of Business
 Haas School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nouscom AG
Nouscom AG Pharmaceuticals: MajorHealth Technology Operates as an oncology company that develops immunotherapies | Health Technology |
Nouscom Srl
Nouscom Srl Miscellaneous Commercial ServicesCommercial Services Operates as a next-generation immunotherapy company that develops engineered viral vectored vaccines for treatment of cancer | Commercial Services |
- Stock Market
- Insiders
- John McDonald
